Categories: NewsPatient Care

Neuma Innovations’ Single-Use IV Disinfecting Cap Improves CLABSI Prevention and Deters Central Line Abuse by IVDU Patients

Neuma Develops Disinfecting Cap That Mechanically Cannot Be Used More Than Once

PALO ALTO, CA / ACCESSWIRE / July 11, 2023 / Neuma Innovations™, creator of the original Neuma Clamp™ that deters and detects central line abuse by IVDU (intravenous drug using) patients, today announced the development of a new disinfecting cap that prevents reuse and is tamper-evident.

Neuma Innovations
Neuma Innovations Logo

“We’ve been working closely with infusion professionals since 2015 to design solutions to problems associated with central line blood infections. We learned that about 28% of caregivers use the same disinfecting cap more than once, which obviously compromises the caps’ effectiveness. Our team set out to design a simple device that, because it can’t be reattached after the first use, dramatically improves compliance,” said Hal Rucker, President of Neuma Innovations. “The added benefit is that our cap also protects lines from patients who use their lines to self-inject illicit drugs.”

NO CHANGES TO WORKFLOWS

The Neuma Cap™ disinfects, approaches 100% compliance, minimizes the harmful consequences of abuse by IVDU patients, facilitates the discharge to SNF and OPAT care, and fits seamlessly into existing workflows.

“The Neuma Cap genuinely ensures the enforcement of single-use protocols while its price point remains on par with comparable alternatives,” said Amy Duncan, Director of Business Development. “The ingenuity of Neuma’s product lies in its indistinguishable resemblance to conventional disinfecting caps without requiring any changes in workflow. From the perspective of clinicians, the Neuma Cap is a frictionless industry disrupter for optimal patient care.”

About Neuma Innovations

Neuma Innovations develops simple medical products to solve complex medical problems.

Neuma Caps and Neuma Clamps are patent-protected. Neuma, Neuma Innovations, Neuma Clamp, Neuma Central Line Protection Clamp, Neuma Cap, and Neuma Disinfecting Cap are trademarks of Neuma Innovations, LLC. All Rights Reserved.

Copyright © 2023 Neuma Innovations LLC

Contact Information

Hal Rucker
President
hrucker@neumainnovations.com
(650) 759-1203

SOURCE: Neuma Innovations

View source version on accesswire.com:
https://www.accesswire.com/766774/Neuma-Innovations-Single-Use-IV-Disinfecting-Cap-Improves-CLABSI-Prevention-and-Deters-Central-Line-Abuse-by-IVDU-Patients

Staff

Recent Posts

Vaxxas Secures TGA Licence to Manufacture Therapeutic Goods

Milestone enables GMP manufacturing to accelerate clinical trials and transform global vaccine delivery BRISBANE, Australia…

18 hours ago

InnoCare Announces Achievement of Primary Endpoint in Phase IIb Study of Orelabrutinib for SLE and Approval of Phase III Clinical Trial

BEIJING, Dec. 14, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading…

18 hours ago

President Trump’s Cannabis Decision Is Coming – And Why MMJ International Holdings Wins Either Way

12 Month Timeline - How Cannabis Rescheduling Actually Takes EffectAnnouncementPresident signals intent or issues executive…

1 day ago

Accelerating Patient Recruitment and Research Excellence: TrialWire® Supports Endpoints Clinical Trials Day NYC 2025

NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- TrialWire®, the industry’s fastest, intelligent patient recruitment…

2 days ago

Genesis Healthcare Remains Committed to Securing Longterm Stability

The skilled nursing, assisted and senior living provider reiterates dedication to a financial restructuring process…

2 days ago